Examining 2013 publications, researchers spotlight the surge in gastric cancer immunotherapy research, with China dominating contributions. Keywords like “tumor microenvironment” and “adoptive immunotherapy” emerged as hotspots. Analysis of clinical trials underscores progress, emphasizing immune checkpoint inhibitors and chimeric antigen receptor T-cells as promising options. The study calls for future research fusing immunotherapies with conventional treatments, envisioning a collaborative approach for enhanced gastric cancer management.
Journal Article by Li YN, Xie B (…) Guo R et 5 al. in World J Gastroenterol
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.